Invention Grant
US09266858B2 Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione
有权
合成3-（5-氨基-2-甲基-4-氧代喹唑啉-3（4H） - 基）哌啶-2,6-二酮
- Patent Title: Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione
- Patent Title (中): 合成3-（5-氨基-2-甲基-4-氧代喹唑啉-3（4H） - 基）哌啶-2,6-二酮
-
Application No.: US14736146Application Date: 2015-06-10
-
Publication No.: US09266858B2Publication Date: 2016-02-23
- Inventor: Alexander L. Ruchelman , Benjamin M. Cohen , Anusuya Choudhury , Matthew M. Kreilein , William W. Leong , Hon-Wah Man
- Applicant: Celgene Corporation
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- Main IPC: C07D401/04
- IPC: C07D401/04
Abstract:
Provided herein are processes for the preparation of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione, or an enantiomer or a mixture of enantiomers thereof; or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20150274694A1 SYNTHESIS OF 3-(5-AMINO-2-METHYL-4-OXOQUINAZOLIN-3(4H)-YL)PIPERIDINE-2,6-DIONE Public/Granted day:2015-10-01
Information query
